299 related articles for article (PubMed ID: 27784003)
1. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
Zhou X; Han D; Xu R; Wu H; Qu C; Wang F; Wang X; Zhao Y
Oncotarget; 2016 Dec; 7(49):80223-80237. PubMed ID: 27784003
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
3. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
[TBL] [Abstract][Full Text] [Related]
4. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
[TBL] [Abstract][Full Text] [Related]
6. A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet.
Zhou X; Han D; Xu R; Li S; Wu H; Qu C; Wang F; Wang X; Zhao Y
PLoS One; 2014; 9(12):e115148. PubMed ID: 25502558
[TBL] [Abstract][Full Text] [Related]
7. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
[TBL] [Abstract][Full Text] [Related]
9. C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis.
Rahman K; Liu Y; Kumar P; Smith T; Thorn NE; Farris AB; Anania FA
Lab Invest; 2016 Aug; 96(8):895-908. PubMed ID: 27239734
[TBL] [Abstract][Full Text] [Related]
10. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
[TBL] [Abstract][Full Text] [Related]
11. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
Su YB; Li TH; Huang CC; Tsai HC; Huang SF; Hsieh YC; Yang YY; Huang YH; Hou MC; Lin HC
PLoS One; 2018; 13(4):e0194867. PubMed ID: 29684027
[TBL] [Abstract][Full Text] [Related]
12. Glucose regulated protein 78 is potentially an important player in the development of nonalcoholic steatohepatitis.
Zhou X; Han D; Yang X; Wang X; Qiao A
Gene; 2017 Dec; 637():138-144. PubMed ID: 28951310
[TBL] [Abstract][Full Text] [Related]
13. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
14. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
15. Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress.
Jia Y; Yee JK; Wang C; Nikolaenko L; Diaz-Arjonilla M; Cohen JN; French SW; Liu PY; Lue Y; Lee WP; Swerdloff RS
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E366-E376. PubMed ID: 28928235
[TBL] [Abstract][Full Text] [Related]
16. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function.
Wang YC; Jin QM; Kong WZ; Chen J
Int J Clin Exp Pathol; 2015; 8(5):5203-9. PubMed ID: 26191218
[TBL] [Abstract][Full Text] [Related]
18. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]